Abivax Sa ADR (ABVX) Stock Price, Quote & News

Company Profile

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod that is in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis, as well as in Phase 2b clinical trial to treat patients with Crohn's disease. The company was incorporat...

Industry: Biotechnology

Sector: Healthcare

Phone: 33 1 53 83 09 63

Website: www.abivax.com

Address:

7-11 boulevard Haussmann, Paris, France

deepak1285 Mar. 21 at 4:35 PM

$ABVX it’s annoying this board is just mostly about sls or cvkd

4 · Reply

VenitaCavendera Mar. 21 at 4:19 PM

$CVKD Cadrenal Therapeutics Highlights Research Supporting 12-LOX Inhibition in Reducing Inflammation in Obesity and Type 2 Diabetes https://www.stocktitan.net/news/CVKD/cadrenal-therapeutics-highlights-research-supporting-12-lox-mbmap9qco4op.html $ABVX $DASH $LW $RKLX

0 · Reply

Machiaveltrade Mar. 21 at 3:42 PM

$ABVX Shoping for sure monday 😀 no selling for me just add more and more…

0 · Reply

IronManResurrection Mar. 21 at 3:42 PM

$SLS not sure how to spin the shelf registration. For a supposed buyout target that wasn’t indicating commercialization was on the roadmap, what is the money for? Or, you go with its to operate from a position of strength in BO negotiations. $ABVX dumped a ton of stock on everyone’s head on approval and went to the stars, so que sera sera.

2 · Reply

MetalFistSlip Mar. 21 at 3:22 PM

$SLS Bears will tell you the ATM is bad… yeah they said the same about CAPR when they did the same thing… And don’t even get me started on $ABVX … The truth is, if you are posting about this like it’s a bad thing you are either don’t understand how this works, are a paid basher, or a troll…. Read post below for more… shout out @yG19

1 · Reply

Jesse1011 Mar. 21 at 1:36 PM

$ABVX asked chat GPT “What is the cost to bring a FDA drug to market?” FOOD FOR THOUGHT 🤔

0 · Reply

GoodTidings Mar. 21 at 12:09 PM

$SLS Anson is what is called a facilitating financial partner... They support Sellas in financial structuring... Exercising warrants in this phase in anticipation of a BO makes sense to make it an attractive BO target combined with an S-3 shelve is a strategy which is seen earlier by CIDAR and $ABVX... It's a prelude to strengthening negotiation position while at the same time making it an attractive BO target by clearing its balance sheet and making it transparant... 🤔🤔🤔

0 · Reply

MrACD Mar. 21 at 10:59 AM

$ABVX $SLS A very possible glimpse into the future.

1 · Reply

MrACD Mar. 21 at 10:56 AM

$SLS I remember $ABVX did the same ATM for $150M several months before their positive P3 resulted in a 600% gain. The price was $11 at the time of ATM and currently trades at $118. During that rise, the company executed 2 public offerings and are seemingly close to a buyout situation. https://www.globenewswire.com/news-release/2024/11/19/2984042/0/en/Abivax-Establishes-an-At-the-Market-ATM-Program-on-Nasdaq.html

1 · Reply

TomRozz Mar. 21 at 3:35 AM

$ABVX expext 15-20 % over reaction dip monday. Need good flush of retail chasers hoping for quick BO bucks 💀

0 · Reply

2 Healthcare Stocks to Buy Before They Get Bought Out

Wed, 18 Mar 2026 01:35:00 -0400 - 3 days ago

AMG TimesSquare Small Cap Growth Fund Q4 2025 Performance Insights

Mon, 16 Mar 2026 10:52:47 -0400 - 5 days ago

Abivax: Maintaining 'Strong Buy' On Buyout Speculation And Obefazimod Advancement

2026-03-16T14:32:10.000Z - 5 days ago

Jefferies Initiates Coverage on Abivax (ABVX) with Buy Rating and $160 Price Target | ABVX ...

2026-03-12T15:57:34.000Z - 9 days ago

Abivax (ABVX) Shares Surge Amid Denial of AstraZeneca Takeover Report

Mar 12, 2026, 10:33 AM EDT - 9 days ago

Abivax spokesperson denies takeover rumors reported by French media

ABVX

2026-03-12T11:25:57.000Z - 9 days ago

AstraZeneca (AZN) Obtains Exclusive Negotiation Period with Abivax

2026-03-12T11:25:29.000Z - 9 days ago

AstraZeneca (AZN) Engages in Exclusive Takeover Talks with Abivax

2026-03-12T11:25:17.000Z - 9 days ago

AstraZeneca (AZN) Enters Exclusive Agreement Boosting Abivax Shares

2026-03-12T10:46:52.000Z - 9 days ago

Eli Lilly Could Rejoin Abivax Bidding If AstraZeneca Misses Deadline

Mar 12, 2026, 6:46 AM EDT - 9 days ago

Eli Lilly Could Rejoin Abivax Bidding If AstraZeneca Misses Deadline

ABVX LLY

Wed, 11 Mar 2026 08:18:00 -0400 - 10 days ago

Harbor Health Care ETF Q4 2025 Portfolio Review

Tue, 10 Mar 2026 16:00:00 -0400 - 11 days ago

Billionaire Steve Cohen Owns Shares of This Stock That Has Soared 1,600% in The Past Year

Fri, 27 Feb 2026 14:45:00 -0500 - 22 days ago

2 Reasons Abivax Stock Could 10X by 2036

2026-02-25T10:30:18.000Z - 24 days ago

BTIG Reiterates Buy Rating for Abivax (ABVX) with $150 Price Target | ABVX Stock News

2026-02-24T12:27:38.000Z - 25 days ago

Wedbush Rates Abivax (ABVX) as Underperform with Cautious Outlook

2026-02-22T19:25:16.000Z - 27 days ago

Abivax (ABVX) Highlights Promising Obefazimod Data at ECCO Congress

Feb 21, 2026, 6:00 AM EST - 4 weeks ago

Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026

ABVX

Tue, 17 Feb 2026 13:25:00 -0500 - 4 weeks ago

Alger Mid Cap Growth Fund Q4 2025 Portfolio Update

Tue, 10 Feb 2026 20:11:00 -0500 - 5 weeks ago

Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.

Fri, 30 Jan 2026 15:30:00 -0500 - 7 weeks ago

Better Long-Term Buy: This Emerging Player or the Industry Leader?

Thu, 29 Jan 2026 22:30:00 -0500 - 7 weeks ago

Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance

Jan 20, 2026, 6:01 AM EST - 2 months ago

Abivax CEO dismisses 'noise' around rumored Eli Lilly bid

ABVX LLY

Mon, 19 Jan 2026 15:45:00 -0500 - 2 months ago

Prediction: This Healthcare Stock Could Soar by 72% in 2026

Mon, 12 Jan 2026 12:31:38 -0500 - 2 months ago

Abivax: Don't Just Buy The Rumor, Buy The Fundamentals

Jan 12, 2026, 9:49 AM EST - 2 months ago

France has had no request for investment approval in biotech Abivax - official

ABVX LLY

Jan 12, 2026, 9:32 AM EST - 2 months ago

Abivax stock rockets 30% on Eli Lilly takeover speculation

ABVX LLY

Jan 12, 2026, 5:03 AM EST - 2 months ago

Abivax Surges on Report Eli Lilly is Preparing $17.5 Billion Bid

ABVX LLY

Jan 12, 2026, 4:38 AM EST - 2 months ago

Abivax shares soar 23% as media report reignites M&A chatter

ABVX LLY

Jan 9, 2026, 6:54 AM EST - 2 months ago

A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year

ABVX LLY

Jan 7, 2026, 4:05 PM EST - 2 months ago

Abivax Provides 2026 Corporate Outlook

ABVX

Tue, 23 Dec 2025 06:41:51 -0500 - 3 months ago

Abivax: Here's Why Eli Lilly Could Want Its Oral Ulcerative Colitis Therapy

Mon, 22 Dec 2025 19:09:18 -0500 - 3 months ago

Why Abivax Stock Was on Fire Today

Dec 18, 2025, 4:05 PM EST - 3 months ago

Abivax to be Added to Nasdaq Biotechnology Index

ABVX

Dec 17, 2025, 4:05 PM EST - 3 months ago

Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings

ABVX

Thu, 11 Dec 2025 16:11:03 -0500 - 3 months ago

Abivax: "Strong Buy" On Obefazimod New UC Data And Maintenance Results Coming Q2 2026

Dec 10, 2025, 12:42 PM EST - 3 months ago

What's Happening With French Biotech Abivax Stock On Wednesday?

ABVX

Dec 10, 2025, 5:52 AM EST - 3 months ago

French biotech Abivax's shares climb on Eli Lilly bid rumors

ABVX LLY

Tue, 09 Dec 2025 16:45:00 -0500 - 3 months ago

2 Under-the-Radar Stocks That Have Soared This Year

Nov 18, 2025, 12:59 PM EST - 4 months ago

6 Healthcare Stocks With Strong Upward Momentum

ABVX CAH ELAN GH MEDP WGS

Sat, 08 Nov 2025 07:57:19 -0500 - 4 months ago

Abivax: Phase 3 Data Was A Home Run, Top Target For M&A In 2026

Tue, 14 Oct 2025 08:41:43 -0400 - 5 months ago

Abivax: Betting Big On The Next Inflammatory Bowel Disease Blockbuster

Mon, 06 Oct 2025 12:35:19 -0400 - 5 months ago

ABIVAX Société Anonyme (ABVX) Shareholder/Analyst Call Transcript

Oct 6, 2025, 11:05 AM EDT - 5 months ago

Why Is Abivax Stock Trading Higher On Monday?

ABVX

Oct 5, 2025, 11:00 AM EDT - 5 months ago

Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data

ABVX

Sep 29, 2025, 4:05 PM EDT - 6 months ago

Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European Gastroenterology (UEG) Meeting

ABVX

Sep 23, 2025, 4:05 PM EDT - 6 months ago

Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology (UEG) Meeting

ABVX

Sep 12, 2025, 11:45 AM EDT - 6 months ago

Abivax to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review

ABVX

Sep 8, 2025, 4:00 PM EDT - 6 months ago

Abivax Presents First Half 2025 Financial Results

ABVX

Aug 30, 2025, 5:30 AM EDT - 7 months ago

How Hedge Funds Won Big on an Obscure Drugmaker

ABVX

Aug 27, 2025, 12:50 PM EDT - 7 months ago

2 Logical Mid-Cap Biotech Buyout Targets

MLTX

Jul 28, 2025, 4:15 PM EDT - 8 months ago

Abivax Announces Closing of $747.5 Million Public Offering

Jul 25, 2025, 2:00 AM EDT - 8 months ago

Abivax Announces Full Exercise of Underwriters' Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M)

Jul 24, 2025, 4:20 PM EDT - 8 months ago

Abivax: Positive Obefazimod Induction Data Leads To Next 44-Week Maintenance Trial Catalyst

Jul 24, 2025, 8:40 AM EDT - 8 months ago

Abivax announces trading resumption of its ordinary shares on Euronext Paris

Jul 24, 2025, 8:40 AM EDT - 8 months ago

Abivax Announces Pricing of $650M (€554M) Public Offering of American Depositary Shares

Jul 24, 2025, 1:30 AM EDT - 8 months ago

Abivax announces temporary trading halt of its ordinary shares on Euronext Paris

Jul 23, 2025, 4:15 PM EDT - 8 months ago

Abivax Announces Launch of Public Offering

Jul 23, 2025, 3:10 PM EDT - 8 months ago

Abivax: Differentiated Phase 3 Data Ignites A Multi-Billion Dollar Opportunity

Jul 19, 2025, 2:23 AM EDT - 8 months ago

Abivax: Good Entry Point Ahead Of The Mega Catalyst - Phase 3 Data Readout

Jun 11, 2025, 4:00 PM EDT - 10 months ago

Abivax Announces Results of its June 6, 2025 Annual General Meeting

Jun 2, 2025, 4:00 PM EDT - 10 months ago

Abivax Presents First Quarter 2025 Financial Results

Jun 2, 2025, 11:00 AM EDT - 10 months ago

Biotech Bull Case, ABVX International Interest, JNJ & LLY Options Trades

JNJ LLY

Apr 29, 2025, 4:05 PM EDT - 11 months ago

Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis

Apr 22, 2025, 4:05 PM EDT - 11 months ago

Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones

Apr 22, 2025, 4:00 PM EDT - 11 months ago

Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors

Mar 26, 2025, 5:05 PM EDT - 1 year ago

Abivax publishes financial reports with the French and U.S. securities regulatory agencies

deepak1285 Mar. 21 at 4:35 PM

$ABVX it’s annoying this board is just mostly about sls or cvkd

4 · Reply

VenitaCavendera Mar. 21 at 4:19 PM

0 · Reply

Machiaveltrade Mar. 21 at 3:42 PM

$ABVX Shoping for sure monday 😀 no selling for me just add more and more…

0 · Reply

IronManResurrection Mar. 21 at 3:42 PM

2 · Reply

MetalFistSlip Mar. 21 at 3:22 PM

1 · Reply

Jesse1011 Mar. 21 at 1:36 PM

$ABVX asked chat GPT “What is the cost to bring a FDA drug to market?” FOOD FOR THOUGHT 🤔

0 · Reply

GoodTidings Mar. 21 at 12:09 PM

0 · Reply

MrACD Mar. 21 at 10:59 AM

$ABVX $SLS A very possible glimpse into the future.

1 · Reply

MrACD Mar. 21 at 10:56 AM

1 · Reply

TomRozz Mar. 21 at 3:35 AM

$ABVX expext 15-20 % over reaction dip monday. Need good flush of retail chasers hoping for quick BO bucks 💀

0 · Reply

Razgooz Mar. 21 at 1:10 AM

$ABVX whats up with AH MOVE ?

0 · Reply

Yimmiedd Mar. 20 at 10:29 PM

$ABVX yea we all saw that seedy post

0 · Reply

TomRozz Mar. 20 at 10:02 PM

$ABVX No buyout, they will take drug to market. Expect CCO announcement monday.

0 · Reply

BanditQ Mar. 20 at 8:27 PM

$EQ people don't realise how huge this is. No safety concerns like indigo naturalis because of this! $ABVX

0 · Reply

dutchiestocks Mar. 20 at 5:53 PM

$ABVX So 3M due to triple witching day apparantly. Ah well, never to old to learn. Do like the big block trades in the us though 😁💪🏻

0 · Reply

dutchiestocks Mar. 20 at 5:17 PM

$ABVX 3M (!) volume in EU 👀 When did it do that before.... Ow, yeah, right around the end of July '25

1 · Reply

Yimmiedd Mar. 20 at 4:42 PM

$ABVX 🤔

0 · Reply

jollylollylondon8 Mar. 20 at 8:53 AM

$ABVX Monday morning takeover?

1 · Reply

timfris Mar. 20 at 8:33 AM

$ABVX should see a nice day today. If most recent rumor true, maybe news next week.

0 · Reply

AsherLev Mar. 20 at 12:39 AM

$ABVX if earnings still happening on Monday they’ll have to come with update…

0 · Reply

SellasgpsCurativeBAT9 Mar. 19 at 6:50 PM

$SLS $SMMT $IBRX $ABVX My Brothers and sisters let me give you some examples of a positive Oncology phase 3 SMMT went from $4.00 to $44.00 after Harmoni phase 3 and MC of $26 Billion. ABVX went from a $4.50 to $140.00 after phase 3. IBRX went from to $2.00 to $12.00 with a billion shares out. NONE of the 👆 is CURATIVE. 🎤 ✌️🙏❤️‍🩹

0 · Reply

GoAt2OG Mar. 19 at 5:04 PM

$ABVX wrong…

0 · Reply

Market Cap	9.80B
Revenue (ttm)	0.00
Net Income (ttm)	-190.71M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.08

Volume	1,379,900
Avg Vol	1,165,250
Day's Range	N/A - N/A
Shares Out	79.07M
Stochastic %K	59%
Beta	1.00
Analysts	Strong Sell
Price Target	$150.17